Because SET KD has been reported to decrease the protein levels of c-Myc and the phosphorylation levels of Akt in human breast cancer cells16, 22, we first examined the effects of SET KD on these signaling molecules in CIP-m cells (Fig. 4A,B). The gene discussed is MYC; the disease is hereditary sensory and autonomic neuropathy.